Eduardo M. da Cruz

Eduardo M. da Cruz

Auto-generated profile, based on publicly available information

Eduardo M. da Cruz

Department of Cardiology (F.S., N.L., E.V., C.K.A., E.M.d.C., N.M.), Boston Children’s Hospital, Harvard Medical School, MA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
FSFrancesca Sperotto
Francesca Sperotto
NLNora Lang
Nora Lang
MNMeena Nathan
Meena Nathan
AKAditya Kaza
Aditya Kaza
DHDavid M. Hoganson
David M. Hoganson
NMNicola Maschietto
Nicola Maschietto
BACKGROUND: Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. However, subcohorts may benefit from less invasive procedures. Data on transcatheter palliation are limited. METHODS: We present our experience with pulmonary flow restrictors (PFRs) for palliation of neonates with congenital heart disease, including procedural feasibility, technical details, and outcomes. We then compared our subcohort of high-risk single ventricle neonates palliated with PFRs with a similar historical cohort who underwent a hybrid Stage 1. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality. RESULTS: From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5 kilograms [IQR, 2.1–3.3]) underwent a PFR procedure; 15 (88%) had single ventricle physiology; 15 (88%) were high-risk surgical candidates. All procedures were technically successful. At a median follow-up of 6.2 months (IQR, 4.0–10.8), 13 patients (76%) were successfully bridged to surgery (median time since PFR procedure, 2.6 months [IQR, 1.1–4.4]; median weight, 4.9 kilograms [IQR, 3.4–5.8]). Pulmonary arteries grew adequately for age, and devices were easily removed without complications. The all-cause mortality rate before target surgery was 24% (n=4). Compared with the historical hybrid stage 1 cohort (n=23), after adjustment for main confounding (age, weight, intact/severely restrictive atrial septum or left ventricle to coronary fistulae), the PFR procedure was associated with a significantly lower all-cause 6-month mortality risk (adjusted hazard ratio, 0.26 [95% CI, 0.08–0.82]). CONCLUSIONS: Transcatheter palliation with PFR is feasible, safe, and represents an effective strategy for bridging high-risk neonates with congenital heart disease to surgical palliation, complete repair, or transplant while allowing for clinical stabilization and somatic growth.

1 January 1998 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
ECE. Da Cruz
E. Da Cruz
LML. Milella
L. Milella
ACAntonio Francesco Corno
Antonio Francesco Corno
The association of left isomerism with interruption and azygos continuation of the inferior caval vein, anomalous connection of the right pulmonary veins to the right atrium, an interatrial commu nication of sinus venosus type, and tetralogy of Fallot with right aortic arch and anomalous coronary artery has been observed in a 6-month-old patient. As far as we are aware, the association of these congenital car diac malformations has not previously been reported in patients with isomeric left atrial appendages.


2 January 2020
Verified
Book Chapter
Closed access
PDF file
CTCécile Tissot
Cécile Tissot
CPChristina M. Phelps
Christina M. Phelps
ECEduardo M. da Cruz
Eduardo M. da Cruz
SMShelley D. Miyamoto
Shelley D. Miyamoto


1 January 2021
Verified
Book Chapter
Closed access
PDF file
HTHarma K. Turbendian
Harma K. Turbendian
MMMax B. Mitchell
Max B. Mitchell
ECEduardo M. da Cruz
Eduardo M. da Cruz